<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03809000</url>
  </required_header>
  <id_info>
    <org_study_id>RTOG 3506</org_study_id>
    <secondary_id>STEEL</secondary_id>
    <nct_id>NCT03809000</nct_id>
  </id_info>
  <brief_title>A Study of Salvage Radiotherapy With or Without Enzalutamide in Recurrent Prostate Cancer Following Surgery</brief_title>
  <acronym>STEEL</acronym>
  <official_title>STEEL: A Randomized Phase II Trial of Salvage Radiotherapy With Standard vs Enhanced Androgen Deprivation Therapy (With Enzalutamide) in Patients With Post-Prostatectomy PSA Recurrences With Aggressive Disease Features</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>RTOG Foundation, Inc.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Pfizer</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Astellas Pharma Inc</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>RTOG Foundation, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients with post-prostatectomy PSA (Prostate Specific Antigen) recurrences with aggressive&#xD;
      disease features will receive salvage radiation therapy and standard androgen deprivation&#xD;
      therapy (ADT) or enhanced ADT to determine if there is any improvement in progression-free&#xD;
      survival when enhanced ADT is used compared to standard ADT.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PRIMARY OBJECTIVE:&#xD;
&#xD;
      To determine whether, in men with post-prostatectomy PSA (prostate specific antigen)&#xD;
      recurrences with aggressive disease features, salvage radiotherapy (SRT) with enhanced&#xD;
      androgen deprivation therapy (ADT), consisting of enzalutamide (MDV3100) and a GnRH analog,&#xD;
      will improve progression-free survival compared to SRT with standard GnRH analog -based ADT.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 15, 2019</start_date>
  <completion_date type="Anticipated">September 15, 2029</completion_date>
  <primary_completion_date type="Anticipated">September 15, 2024</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Progression-Free Survival (PFS)</measure>
    <time_frame>From the date of randomization to the date of progression, death from any cause or last known follow-up date, assessed up to 5 years.</time_frame>
    <description>The time from the date of randomization to the date of progression, death from any cause or last known follow-up date.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">242</enrollment>
  <condition>Prostate Cancer</condition>
  <arm_group>
    <arm_group_label>Salvage Radiation Therapy + Standard ADT</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Salvage RT will be given 66.0 - 70.2 Gy along with 24 months of a GnRH analog with or without 1-4 months of bicalutamide.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Salvage Radiation Therapy + Enhanced ADT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Salvage RT will be given 66.0 - 70.2 Gy along with 24 months of a GnRH analog + 24 months of enzalutamide.</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Radiation Therapy</intervention_name>
    <description>Radiation Therapy</description>
    <arm_group_label>Salvage Radiation Therapy + Enhanced ADT</arm_group_label>
    <arm_group_label>Salvage Radiation Therapy + Standard ADT</arm_group_label>
    <other_name>RT</other_name>
    <other_name>Three-Dimensional Conformal Radiation Therapy (3D-CRT)</other_name>
    <other_name>Intensity-Modulated Radiation Therapy (IMRT)</other_name>
    <other_name>Image-Guided Radiation Therapy (IGRT)</other_name>
    <other_name>Radiotherapy</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Enzalutamide</intervention_name>
    <description>Anti-androgen</description>
    <arm_group_label>Salvage Radiation Therapy + Enhanced ADT</arm_group_label>
    <other_name>Xtandi®</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bicalutamide</intervention_name>
    <description>Anti-androgen</description>
    <arm_group_label>Salvage Radiation Therapy + Standard ADT</arm_group_label>
    <other_name>Casodex®</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>GnRH analog</intervention_name>
    <description>Anti-androgen</description>
    <arm_group_label>Salvage Radiation Therapy + Enhanced ADT</arm_group_label>
    <arm_group_label>Salvage Radiation Therapy + Standard ADT</arm_group_label>
    <other_name>Gonadotropin-releasing hormone analog</other_name>
    <other_name>Lupron®</other_name>
    <other_name>leuprolide acetate</other_name>
    <other_name>goserelin acetate</other_name>
    <other_name>Eligard™</other_name>
    <other_name>Viadur™</other_name>
    <other_name>Zoldaex®</other_name>
    <other_name>Trelstar®</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Pathologically (histologically) proven adenocarcinoma confirmed by prostatectomy&#xD;
             performed within 10 years prior to registration and any type of radical prostatectomy&#xD;
             is permitted, including retropubic, perineal, laparoscopic or robotically assisted.&#xD;
&#xD;
          -  PSA level (≥ 0.2 ng/mL) within 90 days prior to registration. GnRH analog may be&#xD;
             started no more than 42 days prior study entry, but patients must have a PSA ≥ 0.2&#xD;
             ng/mL prior to starting ADT.&#xD;
&#xD;
          -  Hemoglobin ≥ 9.0 g/dL, independent of transfusion and/or growth factors within 90 days&#xD;
             prior to registration.&#xD;
&#xD;
          -  Platelet count ≥ 75,000 x 10^9/µL independent of transfusion and/or growth factors&#xD;
             within 90 days prior to registration.&#xD;
&#xD;
          -  At least 1 of the following aggressive features:&#xD;
&#xD;
               -  Gleason score of 8-10 (note any Gleason score is eligible)&#xD;
&#xD;
               -  Seminal vesicle invasion (SVI) (note any pT stage [AJCC v8.0] is eligible but a&#xD;
                  pT stage&#xD;
&#xD;
                  ≥ pT3b is considered aggressive)&#xD;
&#xD;
               -  Locoregional node involvement at radical prostatectomy (pN1)&#xD;
&#xD;
               -  Persistently elevated PSA post-RP nadir (PEPP) defined as PSA &gt; 0.1 ng/mL after&#xD;
                  radical prostatectomy&#xD;
&#xD;
          -  Serum albumin ≥ 3.0 g/dL within 90 days prior to registration&#xD;
&#xD;
          -  GFR ≥35 mL/min estimated by Cockcroft-Gault or measured directly by 24 hour urine&#xD;
             creatinine within 90 days prior to registration.&#xD;
&#xD;
          -  Serum total bilirubin ≤1.5 × ULN (Note: In subjects with Gilbert's syndrome, if total&#xD;
             bilirubin is &gt;1.5 × ULN, measure direct and indirect bilirubin and if direct bilirubin&#xD;
             is ≤1.5 × ULN, subject is eligible) within 90 days prior to registration.&#xD;
&#xD;
          -  Aspartate aminotransferase (AST) or alanine aminotransferase (ALT) &lt;2.5 × ULN within&#xD;
             90 days prior to registration.&#xD;
&#xD;
          -  Testosterone &gt;50 ng/dL within 90 days prior to registration. Prior androgen&#xD;
             deprivation (GnRH analog and/or non-steroidal antiandrogen) therapy is allowed&#xD;
             provided that serum testosterone concentration must be ≥ 50 ng/dL prior to&#xD;
             registration or starting ADT, whichever occurs first; 5-alpha reductase inhibitors&#xD;
             will not impact eligibility, but must be discontinued prior to starting protocol&#xD;
             treatment.&#xD;
&#xD;
          -  History and physical with ECOG Performance Status 0-1 or within 90 days prior to&#xD;
             registration.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Definitive clinical or radiologic evidence of metastatic disease with the exception of&#xD;
             locoregional lymph nodes.&#xD;
&#xD;
          -  Prior invasive malignancy (except non-melanomatous skin cancer carcinoma in situ of&#xD;
             the male breast, penis, oral cavity, or stage Ta of the bladder, or stage I completely&#xD;
             resected melanoma) unless disease free for a minimum of 2 years).&#xD;
&#xD;
          -  Prior systemic chemotherapy for the study cancer. Note: prior chemotherapy for a&#xD;
             different cancer is allowable.&#xD;
&#xD;
          -  Prior radiotherapy to the region of the study cancer that would result in overlap of&#xD;
             radiation therapy fields.&#xD;
&#xD;
          -  History of any of the following:&#xD;
&#xD;
               -  Documented inflammatory bowel disease&#xD;
&#xD;
               -  Transmural myocardial infarction within the last 4 months prior to registration.&#xD;
&#xD;
               -  New York Heart Association Functional Classification III/IV within 4 months prior&#xD;
                  to registration.&#xD;
&#xD;
               -  Unstable angina and/or congestive heart failure requiring hospitalization within&#xD;
                  the last 4 months prior to registration&#xD;
&#xD;
               -  History of loss of consciousness or transient ischemic attack within 12 months&#xD;
                  prior to randomization&#xD;
&#xD;
               -  History of seizure disorder or condition that may predispose to seizure (e.g.&#xD;
                  prior cortical stroke or significant brain trauma)&#xD;
&#xD;
               -  History of uncontrolled hypertension defined as a sustained systolic blood&#xD;
                  pressure in excess of 150 mmHg or a sustained diastolic blood pressure in excess&#xD;
                  of 90 mmHg despite optimized antihypertensive therapy.&#xD;
&#xD;
               -  History of repeated falls and fractures over the past 12 months that in the&#xD;
                  opinion of the treating investigator would put the patient at risk for poor bone&#xD;
                  outcomes from androgen receptor targeted therapy&#xD;
&#xD;
          -  Known gastrointestinal disorder affecting absorption of oral medications.&#xD;
&#xD;
          -  Active uncontrolled infection defined as an identified infectious condition that&#xD;
             requires active therapy that has not yet been completed.&#xD;
&#xD;
          -  HIV positive patients with CD4 count &lt; 200 cells/microliter within 30 days prior to&#xD;
             registration OR HIV patients under treatment with highly active antiretroviral therapy&#xD;
             (HAART) within 30 days prior to registration regardless of CD4 count. Note: HIV&#xD;
             testing is not required for eligibility for this protocol as it is self-reported. This&#xD;
             exclusion criterion is necessary because the treatments involved in this protocol may&#xD;
             be immunosuppressive and/or interact with HAART.&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Edwin Posadas, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>RTOG Foundation</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hiram Gay, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>RTOG Foundation</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Edwin Posadas, MD</last_name>
    <phone>310-423-7600</phone>
    <email>edwin.posadas@csmc.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Arizona Center for Cancer Care - Gilbert</name>
      <address>
        <city>Gilbert</city>
        <state>Arizona</state>
        <zip>85297</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Penny Labriola</last_name>
      <phone>623-773-2873</phone>
      <email>penny.labriola@arizonaccc.com</email>
    </contact>
    <investigator>
      <last_name>Terry Lee, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Arizona Center for Cancer Care - Peoria</name>
      <address>
        <city>Peoria</city>
        <state>Arizona</state>
        <zip>85381</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Penny Labriola</last_name>
      <phone>623-773-2873</phone>
      <email>penny.labriola@arizonaccc.com</email>
    </contact>
    <investigator>
      <last_name>Terry Lee, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Arizona Center for Cancer Care - Phoenix</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85027</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Penny Labriola</last_name>
      <phone>623-773-2873</phone>
      <email>penny.labriola@arizonaccc.com</email>
    </contact>
    <investigator>
      <last_name>Terry Lee, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Arizona Center for Cancer Care - Scottsdale East</name>
      <address>
        <city>Scottsdale</city>
        <state>Arizona</state>
        <zip>85251</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Penny Labriola</last_name>
      <phone>623-773-2873</phone>
      <email>penny.labriola@arizonaccc.com</email>
    </contact>
    <investigator>
      <last_name>Terry Lee, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Arizona Center for Cancer Care - Scottsdale North</name>
      <address>
        <city>Scottsdale</city>
        <state>Arizona</state>
        <zip>85258</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Penny Labriola</last_name>
      <phone>623-773-2873</phone>
      <email>penny.labriola@arizonaccc.com</email>
    </contact>
    <investigator>
      <last_name>Terry Lee, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Arizona Center for Cancer Care - Surprise</name>
      <address>
        <city>Surprise</city>
        <state>Arizona</state>
        <zip>85374</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Penny Labriola</last_name>
      <phone>623-773-2873</phone>
      <email>penny.labriola@arizonaccc.com</email>
    </contact>
    <investigator>
      <last_name>Terry Lee, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Marin Cancer Care, Inc.</name>
      <address>
        <city>Greenbrae</city>
        <state>California</state>
        <zip>94904</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jaime Chang</last_name>
      <phone>415-925-5040</phone>
      <email>jchang@marincancercare.com</email>
    </contact>
    <investigator>
      <last_name>Llyod Miyawaki, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Marin Health Medical Center</name>
      <address>
        <city>Greenbrae</city>
        <state>California</state>
        <zip>94904</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jaime Chang</last_name>
      <phone>415-925-5040</phone>
      <email>jchang@marincancercare.com</email>
    </contact>
    <investigator>
      <last_name>Lloyd Miyawaki, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Southern California</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90033</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shamim Jhimlee</last_name>
      <phone>323-865-3071</phone>
      <email>shamim.jhimlee@med.usc.edu</email>
    </contact>
    <investigator>
      <last_name>Leslie Ballas, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>USC Medical Center - Los Angeles County</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90033</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shamim Jhimlee</last_name>
      <phone>323-865-3071</phone>
      <email>shamim.jhimlee@med.usc.edu</email>
    </contact>
    <investigator>
      <last_name>Leslie Ballas, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cedars-Sinai Medical Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90048</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jenica Custodio</last_name>
      <phone>310-423-0277</phone>
      <email>Jenica.Custodio@cshs.org</email>
    </contact>
    <investigator>
      <last_name>Howard Sandler, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Roseville Radiation Oncology Center</name>
      <address>
        <city>Roseville</city>
        <state>California</state>
        <zip>95661</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michele Pierini</last_name>
      <phone>916-454-6994</phone>
      <email>pierinmm@sutterhealth.org</email>
    </contact>
    <investigator>
      <last_name>Christopher Jones, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sutter Roseville Medical Center</name>
      <address>
        <city>Roseville</city>
        <state>California</state>
        <zip>95661</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michele Pierini</last_name>
      <phone>916-454-6994</phone>
      <email>pierinmm@sutterhealth.org</email>
    </contact>
    <investigator>
      <last_name>Christopher Jones, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sutter Medical Center Sacramento</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95816</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michele Pierini</last_name>
      <phone>916-454-6994</phone>
      <email>pierinmm@sutterhealth.org</email>
    </contact>
    <investigator>
      <last_name>Christopher Jones, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of California, San Francisco</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94158</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jamese Johnson</last_name>
      <phone>415-476-3048</phone>
      <email>jamese.johnson@ucsf.edu</email>
    </contact>
    <investigator>
      <last_name>Anthony Wong, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Valley View Hospital Cancer Center</name>
      <address>
        <city>Glenwood Springs</city>
        <state>Colorado</state>
        <zip>81601</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cheryl Page</last_name>
      <phone>970-384-7574</phone>
      <email>cheryl.page@vvh.org</email>
    </contact>
    <investigator>
      <last_name>Peter Rossi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Florida Health Science Center</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32608</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Casey Walsh</last_name>
      <phone>352-265-9727</phone>
      <email>CaseyWalsh@cancer.ufl.edu</email>
    </contact>
    <investigator>
      <last_name>Brian Ramnaraign, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nancy N. &amp; J.C. Lewis Cancer &amp; Research Pavilion</name>
      <address>
        <city>Savannah</city>
        <state>Georgia</state>
        <zip>31405</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carla Meyers</last_name>
      <phone>912-819-8236</phone>
      <email>meyersc@sjchs.org</email>
    </contact>
    <investigator>
      <last_name>John Pablo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rush University Medical Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brittany Ray</last_name>
      <phone>312-942-1537</phone>
      <email>Brittany_J_Ray@rush.edu</email>
    </contact>
    <investigator>
      <last_name>Dian Wang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Decatur Memorial Hospital</name>
      <address>
        <city>Decatur</city>
        <state>Illinois</state>
        <zip>62526</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dianna Richardson</last_name>
      <phone>217-876-4760</phone>
      <email>drichardson@dmhhs.org</email>
    </contact>
    <investigator>
      <last_name>Harold Yoon, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Crossroads Cancer Center</name>
      <address>
        <city>Effingham</city>
        <state>Illinois</state>
        <zip>62401</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dianna Richardson</last_name>
      <phone>217-876-4760</phone>
      <email>drichardson@dmhhs.org</email>
    </contact>
    <investigator>
      <last_name>Harold Yoon, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Loyola University Medical Center</name>
      <address>
        <city>Maywood</city>
        <state>Illinois</state>
        <zip>60153</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vlora Osmani</last_name>
      <email>vlora.osmani@luhs.org</email>
    </contact>
    <investigator>
      <last_name>Abhishek Solanki, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Kansas Cancer Center</name>
      <address>
        <city>Kansas City</city>
        <state>Kansas</state>
        <zip>66160</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeffrey Smith</last_name>
      <phone>913-588-3083</phone>
      <email>jsmith41@kumc.edu</email>
    </contact>
    <investigator>
      <last_name>Xinglei Shen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kansas University Cancer Center Overland Park</name>
      <address>
        <city>Overland Park</city>
        <state>Kansas</state>
        <zip>66210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeffrey Smith</last_name>
      <phone>913-588-3083</phone>
      <email>jsmith41@kumc.edu</email>
    </contact>
    <investigator>
      <last_name>Xinglei Shen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kansas University Cancer Center Westwood</name>
      <address>
        <city>Westwood</city>
        <state>Kansas</state>
        <zip>66205</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeffrey Smith</last_name>
      <phone>913-588-3083</phone>
      <email>jsmith41@kumc.edu</email>
    </contact>
    <investigator>
      <last_name>Xinglei Shen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>East Jefferson General Hospital</name>
      <address>
        <city>Metairie</city>
        <state>Louisiana</state>
        <zip>70006</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michelle Seeman</last_name>
      <phone>504-568-2428</phone>
      <email>mseema@lsuhsc.edu</email>
    </contact>
    <investigator>
      <last_name>Scott Delacroix, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>LSU Healthcare Network/Metairie Multi-Specialty Clinic</name>
      <address>
        <city>Metairie</city>
        <state>Louisiana</state>
        <zip>70006</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michelle Seeman</last_name>
      <phone>504-568-2428</phone>
      <email>mseema@lsuhsc.edu</email>
    </contact>
    <investigator>
      <last_name>Scott Delacroix, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Coastal Cancer Treatment Center - Bath</name>
      <address>
        <city>Bath</city>
        <state>Maine</state>
        <zip>04530</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Dalton, RN</last_name>
      <phone>207-294-8291</phone>
      <email>jdalton@mmc.org</email>
    </contact>
    <investigator>
      <last_name>Matthew Cheney, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Waldo Count General Hospital - Belfast</name>
      <address>
        <city>Belfast</city>
        <state>Maine</state>
        <zip>04915</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Dalton, RN</last_name>
      <phone>207-294-8291</phone>
      <email>jdalton@mmc.org</email>
    </contact>
    <investigator>
      <last_name>Matthew Cheney, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Maine Health/SMHC Cancer Care and Blood Disorders-Biddeford</name>
      <address>
        <city>Biddeford</city>
        <state>Maine</state>
        <zip>04005</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Dalton, RN</last_name>
      <phone>207-294-8291</phone>
      <email>jdalton@mmc.org</email>
    </contact>
    <investigator>
      <last_name>Matthew Cheney, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Maine Health/Stephens Memorial - Norway</name>
      <address>
        <city>Norway</city>
        <state>Maine</state>
        <zip>04268</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Dalton, RN</last_name>
      <phone>207-294-8291</phone>
    </contact>
    <investigator>
      <last_name>Matthew Cheney, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Maine Medical Center - Bramhall S Portland</name>
      <address>
        <city>Portland</city>
        <state>Maine</state>
        <zip>04102</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Dalton, RN</last_name>
      <phone>207-294-8291</phone>
      <email>jdalton@mmc.org</email>
    </contact>
    <investigator>
      <last_name>Matthew Cheney, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Penobscot Bay Medical Center - Rockport</name>
      <address>
        <city>Rockport</city>
        <state>Maine</state>
        <zip>04856</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Dalton, RN</last_name>
      <phone>207-294-8291</phone>
      <email>jdalton@mmc.org</email>
    </contact>
    <investigator>
      <last_name>Matthew Dalton, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Maine Health CC of York County - Sanford</name>
      <address>
        <city>Sanford</city>
        <state>Maine</state>
        <zip>04073</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Dalton, RN</last_name>
      <phone>207-294-8291</phone>
      <email>jdalton@mmc.org</email>
    </contact>
    <investigator>
      <last_name>Matthew Cheney, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Maine Health/SMHCancer Care and Blood Disorders - Sanford</name>
      <address>
        <city>Sanford</city>
        <state>Maine</state>
        <zip>04073</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Dalton, RN</last_name>
      <phone>207-294-8291</phone>
      <email>jdalton@mmc.org</email>
    </contact>
    <investigator>
      <last_name>Matthew Cheney, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Maine Medical Cancer Center - Scarborough Campus</name>
      <address>
        <city>Scarborough</city>
        <state>Maine</state>
        <zip>04074</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Dalton, RN</last_name>
      <phone>207-294-8291</phone>
      <email>jdalton@mmc.org</email>
    </contact>
    <investigator>
      <last_name>Matthew Cheney, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Maine Medical Partners - South Portland</name>
      <address>
        <city>South Portland</city>
        <state>Maine</state>
        <zip>04106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Dalton, RN</last_name>
      <phone>207-294-8291</phone>
      <email>jdalton@mmc.org</email>
    </contact>
    <investigator>
      <last_name>Matthew Cheney, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>McLaren Cancer Institute - Bloomfield</name>
      <address>
        <city>Bloomfield</city>
        <state>Michigan</state>
        <zip>48302</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Supraja Chalasani</last_name>
      <phone>313-576-9732</phone>
      <email>chalasas@karmanos.org</email>
    </contact>
    <investigator>
      <last_name>Kiran Devisetty, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>21st Century Oncology MHP - Clarkston</name>
      <address>
        <city>Clarkston</city>
        <state>Michigan</state>
        <zip>48346</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rudolf Ross</last_name>
      <phone>941-833-5700</phone>
      <email>rudi.ross@21co.com</email>
    </contact>
    <investigator>
      <last_name>Thomas Boike, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>McLaren Cancer Institute - Clarkston</name>
      <address>
        <city>Clarkston</city>
        <state>Michigan</state>
        <zip>48346</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Supraja Chalasani</last_name>
      <phone>313-576-9732</phone>
      <email>chalasas@karmanos.org</email>
    </contact>
    <investigator>
      <last_name>Kiran Devisetty, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>William Beaumont Hospital - Dearborn</name>
      <address>
        <city>Dearborn</city>
        <state>Michigan</state>
        <zip>48124</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melissa Lurie</last_name>
      <phone>248-551-0735</phone>
      <email>melissa.lurie@beaumont.org</email>
    </contact>
    <investigator>
      <last_name>Daniel Krauss, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Wayne State/Karmanos Cancer Institute</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Supraja Chalasas</last_name>
      <phone>313-576-9732</phone>
      <email>chalasas@karmanos.org</email>
    </contact>
    <investigator>
      <last_name>Kiran Devisetty, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>21st Century Oncology MHP - Farmington</name>
      <address>
        <city>Farmington Hills</city>
        <state>Michigan</state>
        <zip>48334</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rudolf Ross</last_name>
      <phone>941-833-5700</phone>
      <email>rudi.ross@21co.com</email>
    </contact>
    <investigator>
      <last_name>Thomas Boike, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>McLaren Cancer Institute - Flint</name>
      <address>
        <city>Flint</city>
        <state>Michigan</state>
        <zip>48532</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Supraja Chalasas</last_name>
      <phone>313-576-9732</phone>
      <email>chalasas@karmanos.org</email>
    </contact>
    <investigator>
      <last_name>Amit Bhatt, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Singh and Arora Hematology Oncology PC</name>
      <address>
        <city>Flint</city>
        <state>Michigan</state>
        <zip>48532</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Supraja Chalasani</last_name>
      <phone>313-576-9732</phone>
      <email>chalasas@karmanos.org</email>
    </contact>
    <investigator>
      <last_name>Amit Bhatt, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>McLaren Cancer Institute - Greater Lansing</name>
      <address>
        <city>Lansing</city>
        <state>Michigan</state>
        <zip>48910</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Supraja Chalasani</last_name>
      <phone>313-576-9732</phone>
      <email>chalasas@karmanos.org</email>
    </contact>
    <investigator>
      <last_name>Amit Bhatt, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mid-Michigan Physicians - Lansing</name>
      <address>
        <city>Lansing</city>
        <state>Michigan</state>
        <zip>48912</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Supraja Chalasani</last_name>
      <phone>313-576-9732</phone>
      <email>chalasas@karmanos.org</email>
    </contact>
    <investigator>
      <last_name>Amit Bhatt, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>McLaren Cancer Institute - Lapeer Region</name>
      <address>
        <city>Lapeer</city>
        <state>Michigan</state>
        <zip>48446</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Supraja Chalasani</last_name>
      <phone>313-576-9732</phone>
      <email>chalasas@karmanos.org</email>
    </contact>
    <investigator>
      <last_name>Amit Bhatt, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>21st Century Oncology MHP - Macomb</name>
      <address>
        <city>Macomb</city>
        <state>Michigan</state>
        <zip>48044</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rudolf Ross</last_name>
      <phone>941-833-5700</phone>
      <email>rudi.ross@21co.com</email>
    </contact>
    <investigator>
      <last_name>Thomas Boike, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>21st Century Oncology MHP - Madison Heights</name>
      <address>
        <city>Madison Heights</city>
        <state>Michigan</state>
        <zip>48071</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rudolf Ross</last_name>
      <phone>941-833-5700</phone>
      <email>rudi.ross@21co.com</email>
    </contact>
    <investigator>
      <last_name>Thomas Boike, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>McLaren Cancer Institute - Macomb</name>
      <address>
        <city>Mount Clemens</city>
        <state>Michigan</state>
        <zip>48043</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Supraja Chalasani</last_name>
      <phone>313-576-8029</phone>
      <email>chalasas@karmanos.org</email>
    </contact>
    <investigator>
      <last_name>Amit Bhatt, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>McLaren Cancer Institute - Central Michigan</name>
      <address>
        <city>Mount Pleasant</city>
        <state>Michigan</state>
        <zip>48858</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Supraja Chalasani</last_name>
      <phone>313-576-9732</phone>
      <email>chalasas@karmanos.org</email>
    </contact>
    <investigator>
      <last_name>Amit Bhatt, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>McLaren Cancer Institute - Owosso</name>
      <address>
        <city>Owosso</city>
        <state>Michigan</state>
        <zip>48867</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Supraja Chalasani</last_name>
      <phone>313-576-9732</phone>
      <email>chalasas@karmanos.org</email>
    </contact>
    <investigator>
      <last_name>Amit Bhatt, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>McLaren Cancer Institute - Northern Michigan</name>
      <address>
        <city>Petoskey</city>
        <state>Michigan</state>
        <zip>49770</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Supraja Chalasani</last_name>
      <phone>313-576-9732</phone>
      <email>chalasas@karmanos.org</email>
    </contact>
    <investigator>
      <last_name>Amit Bhatt, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>McLaren Cancer Institute - Port Huron</name>
      <address>
        <city>Port Huron</city>
        <state>Michigan</state>
        <zip>48060</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Supraja Chalasani</last_name>
      <phone>313-576-9732</phone>
      <email>chalasas@karmanos.org</email>
    </contact>
    <investigator>
      <last_name>Amit Bhatt, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>William Beaumont Hospital - Royal Oak</name>
      <address>
        <city>Royal Oak</city>
        <state>Michigan</state>
        <zip>48073</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melissa Lurie</last_name>
      <phone>248-551-0735</phone>
      <email>melissa.lurie@beaumont.org</email>
    </contact>
    <investigator>
      <last_name>Daniel Krauss, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>William Beaumont Hospital - Troy</name>
      <address>
        <city>Sterling Heights</city>
        <state>Michigan</state>
        <zip>48314</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melissa Lurie</last_name>
      <phone>248-551-0735</phone>
      <email>melissa.lurie@beaumont.org</email>
    </contact>
    <investigator>
      <last_name>Daniel Krauss, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>21st Century Oncology MHP - Troy</name>
      <address>
        <city>Troy</city>
        <state>Michigan</state>
        <zip>48098</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rudolf Ross</last_name>
      <phone>941-833-5700</phone>
      <email>rudi.ross@21co.com</email>
    </contact>
    <investigator>
      <last_name>Thomas Boike, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mercy Hospital</name>
      <address>
        <city>Coon Rapids</city>
        <state>Minnesota</state>
        <zip>55433</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jacob Maris</last_name>
      <phone>952-993-1905</phone>
      <email>jacob.maris@parknicollet.comcom</email>
    </contact>
    <investigator>
      <last_name>Ryan Funk, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Minnesota Oncology Hematology PA - Maplewood</name>
      <address>
        <city>Maplewood</city>
        <state>Minnesota</state>
        <zip>55109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jacob Maris</last_name>
      <phone>952-993-1905</phone>
      <email>jacob.maris@parknicollet.com</email>
    </contact>
    <investigator>
      <last_name>Ryan Funk, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Coborn Cancer Center</name>
      <address>
        <city>Saint Cloud</city>
        <state>Minnesota</state>
        <zip>56303</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stacy St. Onge</last_name>
      <phone>320-229-5199</phone>
      <phone_ext>70826</phone_ext>
      <email>stacy.stonge@centracare.com</email>
    </contact>
    <investigator>
      <last_name>Donald Jurgens, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>HealthPartners, Inc.</name>
      <address>
        <city>Saint Louis Park</city>
        <state>Minnesota</state>
        <zip>55416</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jacob Maris</last_name>
      <phone>952-993-1905</phone>
      <email>jacob.maris@parknicollet.com</email>
    </contact>
    <investigator>
      <last_name>Ryan Funk, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Regions Hospital</name>
      <address>
        <city>Saint Paul</city>
        <state>Minnesota</state>
        <zip>55101</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jacob Maris</last_name>
      <phone>952-993-1905</phone>
      <email>jacob.maris@parknicollet.com</email>
    </contact>
    <investigator>
      <last_name>Ryan Funk, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kansas University Cancer Center North</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64154</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeffrey Smith</last_name>
      <phone>913-588-3083</phone>
      <email>jsmith41@kumc.edu</email>
    </contact>
    <investigator>
      <last_name>Xinglei Shen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kansas University Cancer Center Lee's Summit</name>
      <address>
        <city>Lee's Summit</city>
        <state>Missouri</state>
        <zip>64064</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeffrey Smith</last_name>
      <phone>913-588-3083</phone>
      <email>jsmith41@kumc.edu</email>
    </contact>
    <investigator>
      <last_name>Xinglei Shen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Washington University School of Medicine</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Luke Verghese</last_name>
      <phone>314-362-8547</phone>
      <email>lverghese@wustl.edu</email>
    </contact>
    <investigator>
      <last_name>Hiram Gay, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Exeter Hospital</name>
      <address>
        <city>Exeter</city>
        <state>New Hampshire</state>
        <zip>03833</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julie Bushey</last_name>
      <phone>603-580-6148</phone>
      <email>jbushey@ehr.org</email>
    </contact>
    <investigator>
      <last_name>Cocav Rauwerdink, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dartmouth Hitchcock Medical Center/Norris Cotton Cancer Center</name>
      <address>
        <city>Lebanon</city>
        <state>New Hampshire</state>
        <zip>03756</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ashley Burns</last_name>
      <phone>603-640-1996</phone>
      <email>ashley.s.burns@hitchcock.org</email>
    </contact>
    <investigator>
      <last_name>Alan Hartford, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Physicians at Oneida</name>
      <address>
        <city>Oneida</city>
        <state>New York</state>
        <zip>13421</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Erin Bingham</last_name>
      <phone>315-464-3603</phone>
      <email>binghame@upstate.edu</email>
    </contact>
    <investigator>
      <last_name>Jeffrey Bogart, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Upstate Cancer Center Radiation Oncology at Oneida</name>
      <address>
        <city>Oneida</city>
        <state>New York</state>
        <zip>13421</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Erin Bingham</last_name>
      <phone>315-464-3603</phone>
      <email>binghame@upstate.edu</email>
    </contact>
    <investigator>
      <last_name>Jeffrey Bogart, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Physicians at Oswego</name>
      <address>
        <city>Oswego</city>
        <state>New York</state>
        <zip>13126</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Erin Bingham</last_name>
      <phone>315-464-3603</phone>
      <email>binghame@upstate.edu</email>
    </contact>
    <investigator>
      <last_name>Jeffery Bogart, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Upstate Cancer Radiation Oncology at Oswego</name>
      <address>
        <city>Oswego</city>
        <state>New York</state>
        <zip>13126</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Erin Bingham</last_name>
      <phone>315-464-3603</phone>
      <email>binghame@upstate.edu</email>
    </contact>
    <investigator>
      <last_name>Jeffrey Bogart, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>SUNY Upstate Medical University</name>
      <address>
        <city>Syracuse</city>
        <state>New York</state>
        <zip>13210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Erin Bingham</last_name>
      <phone>315-464-3603</phone>
      <email>binghame@upstate.edu</email>
    </contact>
    <investigator>
      <last_name>Jeffrey Bogart, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Upstate Cancer Center at Hill Radiation Oncology</name>
      <address>
        <city>Syracuse</city>
        <state>New York</state>
        <zip>13210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Erin Bingham</last_name>
      <phone>315-464-3603</phone>
      <email>binghame@upstate.edu</email>
    </contact>
    <investigator>
      <last_name>Jeffrey Bogart, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UNC Rex Cancer Center</name>
      <address>
        <city>Raleigh</city>
        <state>North Carolina</state>
        <zip>27607</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Glenn Morgan</last_name>
      <phone>919-852-1994</phone>
      <email>glenn.morgan@unchealth.unc.edu</email>
    </contact>
    <investigator>
      <last_name>Rommel Lu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rex Cancer Center of Wakefield</name>
      <address>
        <city>Raleigh</city>
        <state>North Carolina</state>
        <zip>27614</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Glenn Morgan</last_name>
      <phone>919-852-1994</phone>
      <email>glenn.morgan@unchealth.unc.edu</email>
    </contact>
    <investigator>
      <last_name>Rommel Lu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>WellSpan Health - Ephrata Cancer Center</name>
      <address>
        <city>Ephrata</city>
        <state>Pennsylvania</state>
        <zip>17522</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joan Moore</last_name>
      <phone>717-339-2638</phone>
      <email>jmoore@wellspan.org</email>
    </contact>
    <investigator>
      <last_name>Amit Shah, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>WellSpan Health - Adams Cancer Center</name>
      <address>
        <city>Gettysburg</city>
        <state>Pennsylvania</state>
        <zip>17325</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joan Moore</last_name>
      <phone>717-339-2638</phone>
      <email>jmoore@wellspan.org</email>
    </contact>
    <investigator>
      <last_name>Amit Shah, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Penn State Milton S. Hershey Medical Center</name>
      <address>
        <city>Hershey</city>
        <state>Pennsylvania</state>
        <zip>17033</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kathleen Rizzo</last_name>
      <phone>717-531-0003</phone>
      <phone_ext>289630</phone_ext>
      <email>krizzo@pennstatehealth.psu.edu</email>
    </contact>
    <investigator>
      <last_name>Rodney Ellis, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>WellSpan Health - Sechler Family Cancer Center</name>
      <address>
        <city>Lebanon</city>
        <state>Pennsylvania</state>
        <zip>17402</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joan Moore</last_name>
      <phone>717-339-2638</phone>
      <email>jmoore@wellspan.org</email>
    </contact>
    <investigator>
      <last_name>Amit Shah, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Pittsburgh Medical Center - Shadyside Hospital</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15232</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karen Holeva</last_name>
      <phone>412-623-1275</phone>
      <email>holevakd@upmc.edu</email>
    </contact>
    <investigator>
      <last_name>Adam Olson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>WellSpan Health - York Hospital</name>
      <address>
        <city>York</city>
        <state>Pennsylvania</state>
        <zip>17403</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joan Moore</last_name>
      <phone>717-339-2638</phone>
      <email>jmoore@wellspan.org</email>
    </contact>
    <investigator>
      <last_name>Amit Shah, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Gibbs Cancer Center - Pelham</name>
      <address>
        <city>Greer</city>
        <state>South Carolina</state>
        <zip>29650</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marisa Lozada</last_name>
      <phone>864-560-6826</phone>
      <email>mlozada@gibbscc.org</email>
    </contact>
    <investigator>
      <last_name>Michael Humeniuk, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Spartanburg Medical Center</name>
      <address>
        <city>Spartanburg</city>
        <state>South Carolina</state>
        <zip>29303</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marisa Lozada</last_name>
      <phone>864-560-6826</phone>
      <email>mlozada@gibbscc.org</email>
    </contact>
    <investigator>
      <last_name>Michael Humeniuk, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UT Southwestern/Simmons Cancer Center - Dallas</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Liliana Robels</last_name>
      <phone>214-648-8038</phone>
      <email>liliana.robles@utsouthwestern.edu</email>
    </contact>
    <investigator>
      <last_name>Neil Desai, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>American Fork Hospital</name>
      <address>
        <city>American Fork</city>
        <state>Utah</state>
        <zip>84003</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shelby Kirby</last_name>
      <phone>801-507-9471</phone>
      <email>shelby.kirby@imail.org</email>
    </contact>
    <investigator>
      <last_name>Jeffrey Lee, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cedar City Hospital</name>
      <address>
        <city>Cedar City</city>
        <state>Utah</state>
        <zip>84721</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shelby Kirby</last_name>
      <phone>801-507-9471</phone>
      <email>shelby.kirby@imail.org</email>
    </contact>
    <investigator>
      <last_name>Jeffrey Lee, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Logan Regional Medical Center</name>
      <address>
        <city>Logan</city>
        <state>Utah</state>
        <zip>84341</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shelby Kirby</last_name>
      <phone>801-507-9471</phone>
      <email>shelby.kirby@imail.org</email>
    </contact>
    <investigator>
      <last_name>Jeffrey Lee, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Intermountain Medical Center</name>
      <address>
        <city>Murray</city>
        <state>Utah</state>
        <zip>84107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shelby Kirby</last_name>
      <phone>801-507-9471</phone>
      <email>shelby.kirby@imail.org</email>
    </contact>
    <investigator>
      <last_name>Jeffrey Lee, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Utah Valley Regional Medical Center</name>
      <address>
        <city>Provo</city>
        <state>Utah</state>
        <zip>84604</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shelby Kirby</last_name>
      <phone>801-507-9471</phone>
      <email>shelby.kirby@imail.org</email>
    </contact>
    <investigator>
      <last_name>Jeffrey Lee, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dixie Regional Medical Center</name>
      <address>
        <city>Saint George</city>
        <state>Utah</state>
        <zip>84790</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shelby Kirby</last_name>
      <phone>801-507-9471</phone>
      <email>shelby.kirby@imail.org</email>
    </contact>
    <investigator>
      <last_name>Jeffrey Lee, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dartmouth Hitchcock Medical Center/Norris Cancer Ctr. - St. Johnsbury</name>
      <address>
        <city>Saint Johnsbury</city>
        <state>Vermont</state>
        <zip>05819</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ashley Burns</last_name>
      <phone>603-640-1996</phone>
      <email>ashley.s.burns@hitchcock.org</email>
    </contact>
    <investigator>
      <last_name>Alan Hartford, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sentara Cancer Institute at Sentara CarePlex Hospital</name>
      <address>
        <city>Hampton</city>
        <state>Virginia</state>
        <zip>23666</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Newman</last_name>
      <phone>757-388-2406</phone>
      <email>jnnewma1@sentara.com</email>
    </contact>
    <investigator>
      <last_name>Mark Shaves, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sentara Norfolk General Hospital</name>
      <address>
        <city>Norfolk</city>
        <state>Virginia</state>
        <zip>23507</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Newman</last_name>
      <phone>757-388-2406</phone>
      <email>jnnewma1@sentara.com</email>
    </contact>
    <investigator>
      <last_name>Mark Shaves, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sentara Virginia Beach General Hospital</name>
      <address>
        <city>Virginia Beach</city>
        <state>Virginia</state>
        <zip>23454</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Newman</last_name>
      <phone>757-388-2406</phone>
      <email>jnnewma1@sentara.com</email>
    </contact>
    <investigator>
      <last_name>Mark Shaves, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Aspirus Langlade Hospital</name>
      <address>
        <city>Antigo</city>
        <state>Wisconsin</state>
        <zip>54409</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Beth Knetter</last_name>
      <phone>715-847-2353</phone>
      <email>beth.knetter@aspirus.org</email>
    </contact>
    <investigator>
      <last_name>Christopher Platta, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Cancer Center Johnson Creek</name>
      <address>
        <city>Johnson Creek</city>
        <state>Wisconsin</state>
        <zip>53038</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Diana Trask</last_name>
      <phone>608-263-9528</phone>
      <email>trask@humonc.wisc.edu</email>
    </contact>
    <investigator>
      <last_name>John Floberg, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Wisconsin Hospital and Clinics</name>
      <address>
        <city>Madison</city>
        <state>Wisconsin</state>
        <zip>53792</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Diana Trask</last_name>
      <phone>608-263-9528</phone>
      <email>trask@humonc.wisc.edu</email>
    </contact>
    <investigator>
      <last_name>John Floberg, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Aspirus Regional Cancer Center</name>
      <address>
        <city>Wausau</city>
        <state>Wisconsin</state>
        <zip>54401</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Beth Knetter</last_name>
      <phone>715-847-2353</phone>
      <email>beth.knetter@aspirus.org</email>
    </contact>
    <investigator>
      <last_name>Christopher Platta, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Aspirus Cancer Care - Wisconsin Rapids</name>
      <address>
        <city>Wisconsin Rapids</city>
        <state>Wisconsin</state>
        <zip>54494</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Beth Knetter</last_name>
      <phone>715-847-2353</phone>
      <email>beth.knetter@aspirus.org</email>
    </contact>
    <investigator>
      <last_name>Christopher Platta, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Quebec - L'Hotel-Dieu de Quebec</name>
      <address>
        <city>Québec City</city>
        <state>Quebec</state>
        <zip>G1R 2J6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Josee Allard</last_name>
      <phone>418-525-4444</phone>
      <phone_ext>16730</phone_ext>
      <email>josee.allard@chudequebec.ca</email>
    </contact>
    <investigator>
      <last_name>Eric Vigneault, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CIUSS de l'Estrie - Centre Hospitalier Universitaire de Sherbrooke-Fleurimont</name>
      <address>
        <city>Sherbrooke</city>
        <zip>J1H 5N4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sophie Couture</last_name>
      <phone>819-346-1110</phone>
      <phone_ext>14311</phone_ext>
      <email>sophie.couture.ciussse-chus@ssss.gouv.qc.ca</email>
    </contact>
    <investigator>
      <last_name>Myriam Bouchard, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>January 16, 2019</study_first_submitted>
  <study_first_submitted_qc>January 16, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">January 18, 2019</study_first_posted>
  <last_update_submitted>November 17, 2021</last_update_submitted>
  <last_update_submitted_qc>November 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Post-prostatectomy</keyword>
  <keyword>Enzalutamide</keyword>
  <keyword>STEEL</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prostatic Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Leuprolide</mesh_term>
    <mesh_term>Goserelin</mesh_term>
    <mesh_term>Bicalutamide</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

